Come join us on June 25th for a live Webinar: Exploring the New Standard in Clinical Trial Accruals! In the session, Erin and Sharon will share findings from across the industry and host an open discussion on the emerging standards and best practices in clinical trial accruals. Registration link in comments.
Auxilius
Software Development
New York, NY 10,179 followers
Clinical Trial Financial Management Software for Biopharma
About us
Auxilius is a data-driven, clinical trial financial management platform. We help Biotechs take control over trial costs, manage financial risk, and optimize spend in pursuit of trial targets. It’s time to make financial management part of the cure.
- Website
-
https://www.auxili.us
External link for Auxilius
- Industry
- Software Development
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2020
- Specialties
- Clinical Trial Financial Management, Accounting, Finance, Clinical Trials, FP&A, and SaaS
Locations
-
Primary
New York, NY, US
Employees at Auxilius
Updates
-
Check out the latest coverage from Endpoints News on our recent fundraise, led by SignalFire. Excited to continue the progress as we transform #clinicaltrialfinance! https://lnkd.in/e2mzARQ7
-
Exciting News! Auxilius has raised an additional $10M, led by SignalFire, to propel clinical trial financial management, transforming complexity into clarity. For more details read our blog post (https://lnkd.in/e84jSaax), and check out today's coverage from Ngai Yeung at Endpoints News.
I’m excited to announce that Auxilius has raised an additional $10M, led by SignalFire, and with participation from XYZ, Renegade Partners, and CP Overture. This milestone follows an incredible 2023, with 800% revenue growth and expanded partnerships with over 50 leading biopharma companies. Of course, we would not be where we are without such an incredible team (now over 30 “Auxen” strong), or without the partnership of our earliest customers. But the biggest reason we’ve been able to establish the Auxilius platform as an essential part of the biopharma tech stack so quickly is because we are solving a real and massive problem. The Life Sciences industry continues to manage $250B in clinical R&D spend manually, in excel. We think there is a better way. The additional capital will solidify our position as a leader in Clinical Trial Financial Management (CTFM), and empower us to expand our platform to support customers more broadly in all stages of the drug development lifecycle. Getting a drug to market is extremely difficult. We believe that finance and accounting leaders should be equipped to play a role in mitigating both operational complexity and cost. If you’re as passionate about this topic as we are (or stuck in excel), we’d love to hear from you. Together, we can remove financial complexity and risk from clinical R&D to help get more life-changing drugs to market cost effectively. For more details on our journey and future plans, read our blog post (https://lnkd.in/e84jSaax), and check out this morning’s coverage from Ngai Yeung at Endpoints News
-
Feeling bogged down by trial change orders or amendments? Are invoiceables in oncology trials keeping you up at night? Clinical trial finance can be tough, especially when managing it in Excel. But there's a better way! A new industry standard is forming, and Auxilius is here to share tips on optimizing clinical trial close processes and the pivotal role of automation. 🌟 #ClinicalTrials #FinanceOptimization #Automation #Auxilius https://lnkd.in/e6DyrSHU
Financial Close Processes for Clinical Trials - What is Gold Standard?
notes.auxili.us
-
2024 Prediction Fact Check : Are trial sponsors (biopharma companies) becoming increasingly intolerant of inefficiency and budget overages? Appears to be TRUE ✅ as there is a shift underway in CRO contract models. For outsourced clinical activities, increasingly today’s top biopharma’s are shifting to an FSP contracting approach versus a full-service outsourcing model. According to Samir Shah, “Nearly 80% of respondents agreed that the ‘one-stop-shop’ claim that many large CROs market is not a cost-effective business model due to the lack of seamlessly integrated service delivery.” Great article from Clinical Leader and check out Auxilius’ other 2024 Industry Predictions. https://lnkd.in/ev9drTVG
-
Controls and SOX compliance surrounding outsourced R&D/Clinical spend is necessary for today's biopharma companies. Crowe and Auxilius teamed up recently for a substantive webinar on the key issues driving critical audit matters, regulatory risk and operational efficiency in clinical trial financial management. Tune-in here for practical considerations on to how to mitigate risk throughout your clinical trial processes. https://lnkd.in/d8CekwGV
2024 GRC Webinar Series: How to mitigate critical risks in your clinical trial processes
event.on24.com
-
Please join Auxilius and Crowe this Thursday, April 25, from 1-2p EST for a CPE-accredited webinar. Part of Crowe's 2024 GRC Webinar Series, this session examines ways to mitigate risks associated with clinical trial processes. https://lnkd.in/eUQsupWg
-
Tuesday marks the first day of spring! Is the Biotech winter thawing? Promising signs exist for the days ahead. Importantly, what did the past year teach us? Auxilius is pleased to share our Annual Report - a reflection of learnings, industry observations and expected trends. https://lnkd.in/dWzsKN9E #biotech #clinicaltrials #pharma #financeandaccounting
2024 Annual Life Sciences Financial Planning & Accounting Report
auxili.us
-
As 2024 is underway, the life science sector faces great growth opportunity along with new industry norms. Products are on the precipice for commercial launch, organizations must stay judicious in capital allocation, and teams face new demands for resource efficiency - specifically around R&D spend and clinical accruals. Auxilius summarizes some observed trends here - check it out! https://hubs.li/Q02nlzs70